. Serum alkaline phosphatase, AST and bilirubin concentration before and after cessation of enalapril therapy A liver biopsy 7 days after admission ( Figure 2 ) showed chronic inflammation in portal tracts (mainly lymphocytic) sometimes related to bile duct proliferation. There was no extension of the infiltrate into the parenchyma and the only evidence of parenchymal damage was the presence of occasional mitoses in the hepatocytes. Steatosis was absent. Centrilobular cholestasis was prominent with bile thrombi in the canaliculi. There was also a large amount of lipofuscin in the centrilobular zones. These appearances are identical to those produced by chlorpromazine hypersensitivity and were therefore thought most likely to be drug-induced. Enalapril, a non-sulphydryl prodrug is hydrolysed enzymatically in the liver to enalaprilic acid, an active angiotensinconverting enzyme inhibitor. Enalaprillacks many of the adverse effects of captopril which are usually associated with the possession of a sulphydryl moietyl .2. There are only two reported cases of hepatotoxicity associated with enalapril therapy':" although unlike the present case neither were associated with jaundice.
Case report
A 67-year-old Caucasian woman was admitted to St Bartholomew's Hospital in 1987 with a 3 day history of yellow sclerae, dark urine, pale stools and pruritis. She had systemic hypertension treated in the past with atenolol and cyclopenthiazide. Six weeks prior to admission, treatment was changed to enalapril 15 mg/day with cyclopenthiazide 250 itWday. There was no history ofjaundice, bloodtransfusion or foreign travel.
On examination she was deeply jaundiced but had no signs of chronic liver disease. Full blood count and plasma urea and electrolytes were normal. Liver biochemistry was markedly abnormal with a bilirubin of 153 Itmolll (normal range 2-17 Itmol/l), alkaline phosphatase 437 iu/l (normal range 25-100 iu/l) and aspartate transaminase (AST)236 iu/l (normal range 10-40 iu/l). Serum amylase and coagulation screen were normal and hepatitis A and B serology was negative. Autoantibody screening was negative and there was no significant rise in viral titres. The Paul Bunnell test was negative. Ultrasound examination of the liver was normal. Enalapril was stopped 3 days following admission. Four days later liver biochemistry was returning towards normal (Figure 1 ). transaminases and a marked rise in the alkaline phosphatase occurred without hyperbilirubinaemia. Liver biopsy revealed parenchymal damage with portal tract fibrosis. Acute hepatitis following enalapril therapy has also been reported" and another case with hyperbilirubinaemia was thought to be attributable to bacteraemia and not directly to enalapril", Although cholestatic jaundice is a well documented complication of the related compound captopril, we believe this to be the first case associated with enalapril. Although many of the adverse effects associated with captopril are attributed to its sulphydryl moiety", this case of intrahepatic cholestasis related to the non-sulphydryl compound enalapril suggests that other molecular determinants are involved. 
Discussion
Captopril-induced cholestatic liver injury has been well documented", but hepatotoxicity with enalapril is extremely rare. We consider that it is highly likely that enalapril was the causative agent in view of the temporal relationship of the clinical and biochemical abnormalities to initiation and cessation of treatment with the drug. The onset ofjaundice was noted six weeks after initiation of enalapril therapy and its cessation was rapidly followed by a resolution of the jaundice and biochemical abnormalities.
There is one previous case of probable enalapril-provoked cholestatic liver injury:' in which a mild increase in the In 1986 Robinson! and Miller" both described patients fabricating a history of AIDS to obtain admission to hospital. There are, however, no reports of Munchausen's syndrome" in patients known to be HIV positive.
Case report
A 28-year-old man presented with a 24-h history of rectal bleeding of sufficient quantity to produce a pool of blood in his bed. He did not give any other history of gastrointestinal disease but said that he had lost two stone in weight.
He volunteered the information that he was sero-positive for the human immuno-competence virus. He expressed concern that he was developing acquired immune deficiency syndrome (AIDS) in his bowel as he had already had radiotherapy for a Kaposi's sarcoma on his right elbow. He had had Hodgkin's disease 5 years previously, which had required diagnostic lymph node biopsies from his neck and was followed by chemotherapy. A recurrence in his caecum required local excision. Treatment was undertaken in Paris where his parents were resident, he failed to attend for follow-up at the Royal Marsden Hospital.
Examination revealed two mature scars on his rightelhow but with no evidence of radiotherapy. He had a long scar Lakartidningen 1987; 84:1270 (Accepted 26 June 1989 over the anterior border of his left sternomastoid and one scar in the right iliac fossa. He had tenderness over the left side of his abdomen, Otherwise examination was normal.
Overnight he had several minor rectal bleeds, while straining to have his bowels open. Unfortunately they were never seen by any staff but he did demonstrate small amounts of blood on his clothing. Sigmoidoscopy revealed a single minor tear of the rectal mucosa and smaller tears at the anal margin. When confronted with the idea that the rectal bleeding might be selfinduced, he initially appeared upset but within one hour he had taken his own discharge from hospital. On Monday of the followingweek he presented to a local general practitioner requesting a prescription for morphine. On Wednesday he arranged an appointment in the Radiotherapy Department and on Friday presented in the Accident & Emergency Department with a history of haematemesis.
His hospital notes revealed several medical admissions within our district with attempted suicide. He had also gained admission under the care of psychiatrists with threats of suicide and a diagnosis of Munchausen's syndrome was made. Prior to these admissions, he had attended medical outpatients for extensive investigation of abdominal pain when no cause was found; it was at this time that he was found to be HIV positive.
Subsequently he was found guilty of robbery of a post office; he told police that he needed the money to buy heroin to take his own life. He created legal history when the Court of Appeal reduced his sentence from 7 to 4 years because a terminally ill person should be allowed 'a measure of hope and to improve his lot'.
Discussion
This combination of Munchausen's syndrome and HIV positivity presents hazards both for the hospital and the doctor. He has a high risk of developing AIDS however his symptoms may be attributed to his Munchausen's syndrome, 0141-0768/90/ 040272-02/$02.00/0 © 1990 The Royal Society of Medicine
